iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDB – Get Free Report) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totaling 18,525 shares, a growth of 83.3% from the September 30th total of 10,107 shares. Approximately 0.8% of the shares of the company are sold short. Based on an average trading volume of 14,228 shares, the short-interest ratio is currently 1.3 days.
iShares LifePath Target Date 2030 ETF Stock Performance
Shares of NYSEARCA:ITDB traded down $0.03 on Monday, hitting $34.80. The company’s stock had a trading volume of 21,496 shares, compared to its average volume of 18,402. iShares LifePath Target Date 2030 ETF has a 12 month low of $32.14 and a 12 month high of $35.65. The company has a market capitalization of $82.82 million, a price-to-earnings ratio of 20.07 and a beta of 0.58. The stock’s 50-day moving average is $35.01 and its two-hundred day moving average is $34.40.
iShares LifePath Target Date 2030 ETF Company Profile
The iShares LifePath Target Date 2030 ETF (ITDB) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2030 ITDB was launched on Oct 17, 2023 and is issued by BlackRock.
Further Reading
- Five stocks we like better than iShares LifePath Target Date 2030 ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AIāThese 5 Stocks Are Getting Paid
Receive News & Ratings for iShares LifePath Target Date 2030 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2030 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
